CN104274704A - Traditional Chinese medicine composition for treating myasthenia gravis - Google Patents
Traditional Chinese medicine composition for treating myasthenia gravis Download PDFInfo
- Publication number
- CN104274704A CN104274704A CN201410583935.7A CN201410583935A CN104274704A CN 104274704 A CN104274704 A CN 104274704A CN 201410583935 A CN201410583935 A CN 201410583935A CN 104274704 A CN104274704 A CN 104274704A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- myasthenia gravis
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating myasthenia gravis. The traditional Chinese medicine composition comprises the following Chinese medicinal raw materials by weight: 10-25g of whorledleaf solomonseal rhizome, 10-20g of anoectochilus formosanus hayata, 5-20g of walnut kernel, 5-15g of radix achyranthis bidentatae, 5-10g of herba cistanche, 3-9g of adenia chevali, 5-10g of acanthopanax, 3-6g of root of Sandhill Tylophora, 3-6g of rust-brown crotalaria, 5-10g of Rhizoma Cimicifugae and 3-6g of malva verticillata. Whorledleaf solomonseal rhizome, walnut kernel, radix achyranthis bidentatae, herba cistanche and the rust-brown crotalaria are used for nourishing the liver and kidneys; adenia chevali, acanthopanax and root of Sandhill Tylophora are used for replenishing qi to invigorate the spleen; rhizoma cimicifugae and malva verticillata are used for strengthening the middle warmer and conserving strength; anoectochilus formosanus hayata is used for clearing heat and inducing diuresis; all the medicines are matched to play a synergistic effect; the traditional Chinese medicine composition is accurate and remarkable in curative effect on myasthenia gravis, high in effective rate and free of toxic and side effects.
Description
Technical field
The invention belongs to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of myasthenia gravis.
Background technology
Myasthenia gravis (myasthenia gracis, be called for short MG) is the immune disease caused by autoantibody, is neuromuscular junction conductive obstruction and the chronic disease that causes.Clinical manifestation is the abnormal fatigue and weak of striped muscle of getting involved, very easily tired, can not voluntary movement, and after having a rest or taking the treatment of anticholinergic medicine, symptom temporarily alleviates or disappears.
This is called myopathy by the myasthenia gravis traditional Chinese medical science.Myopathy just refers to that limbs muscle arteries and veins speeds to delay, weakness, with the passing of time because of can not voluntary movement and cause an amyotrophic class disease.The traditional Chinese medical science thinks that the origin cause of formation of flaccidity is mainly due to " heat " and " void ", and congenital defect, lose the day after tomorrow and support, internal organs virtual loss, caused by functional disorder.
Take turns the viewpoint of theory according to the traditional Chinese medical science five, eyelid position belongs to spleen; According to the viewpoint of viscera theory, spleen governing limbs and muscle, therefore to amyasthenic various clinical syndrome, most utilization traditional Chinese medical science theory of spleen and stomach is as guidance, simultaneously according to the relation of the vital organs of the human body, lung spleen kidney three is dirty in close relations, and therefore this disease has substantial connection with lung and kidney again.Amyasthenic pathogeny and characteristics is that lung spleen is suffered from a deficiency of the kidney, and causes collapse of QI, insufficiency of the spleen mistake fortune, and suffering from a deficiency of the kidney, it is solid to lose, and muscle arteries and veins muscle loses supports, visceral dysfunction, and atrophic debilities of the muscle is unable.Meanwhile, because lung spleen is suffered from a deficiency of the kidney, defend outer mistake solid, and endogenous damp formation causes diseases caused by exogenous pathogenic factor ailment said due to cold or exposure, internal injury phlegm-damp, inside and outside conjunction is attacked, and increases the weight of the state of an illness.
The medicine of current western medical treatment myasthenia gravis mainly contain neostigmine, pyridostigmine, beautiful think bright etc., be anticholinesterase drug, instant effect, but such medicine can only take stopgap measures and can not effect a permanent cure, temporarily can only improve symptom, and side effect is large, can cause hypokalemia, contracted pupil, sialorrhea, stomachache, diarrhoea, perspiration, muscle beat etc.; Hormone and other immunosuppressive therapy can Immunosuppression functions, can symptom management, but side effect much and serious again, easily recurs after drug withdrawal.Chinese medicine determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs is by conditioner body immunity function, and reach object of effecting a permanent cure, curative effect is also affirmed.
The traditional Chinese medical science is thought, the pathogenesis of myasthenia gravis is: 1, weakness of the spleen and stomach the spleen being the foundation of acquired constitution, body fluid source of generating QI and blood.As ferritic weakness of the spleen and stomach, or prolonged illness taste cause void, or overstrain undermines taste, and it is not normal that taste are received transportation capabilities, and body fluid source of generating QI and blood is not enough, then QI and blood deficiency, and muscle muscle arteries and veins loses supports, therefore muscle weakness, eyelid hang down or limbs fatigue, or dyspnea etc.2, the kidney being the origin of congenital constitution for deficiency of spleen-YANG and kidneyYANG, the raw marrow of store essential substances, and spleen is the source of the day after tomorrow, transporting and transforming nutrients from foodstuff precise and tiny; Natural endowment is not enough, and insufficiency of kidney-YANG loses, can not warm spleen sun, insufficiency of the spleen inability of food and drink to be digested and transported precise and tiny, and make moist muscle muscle arteries and veins, therefore limb muscle flaccidity is soft unable.3. hepatic and renal YIN deficiency blood stored in the liver, main muscle; Kidney storing essence, main bone; Essence and blood fills Sheng, then muscles and bones is strong, movable normal.Weakness due to chronic disease, injures Liver and kidney, then deficiency of YIN-essence: again because of yin asthenia generating intrinsic heat, brighter liquid impairment of body fluid, and essence and blood loss can not be irrigated and flourish supported muscles then to cause flaccidity soft unable.4. QI and blood deficiency blood is cloudy liquid, has moist, flourish foster effect; Qi being the governor of blood, the capable then blood of gas, the motion of human body body fluid has substantial connection with the promotion of gas invariably, and the deficiency of vital energy can not promote blood vessels, insufficiency of vital energy and blood, flourishly can not support muscle muscle arteries and veins, then cause flaccidity.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of myasthenia gravis.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of myasthenia gravis, be made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 10-25g, Anoectochilus nefiliforme (Nakai) hara 10-20g, semen juglandis 5-20g, Radix Achyranthis Bidentatae 5-15g, Herba Cistanches 5-10g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 3-9g, Radix Et Caulis Acanthopanacis Senticosi 5-10g, Radix Tylophorae arenicolae 3-6g, Herba Crotalariae Ferrugineae 3-6g, Rhizoma Cimicifugae 5-10g, Semen Abutili 3-6g.
Preferably, the Chinese medicine composition for the treatment of myasthenia gravis, is made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 15g, Anoectochilus nefiliforme (Nakai) hara 15g, semen juglandis 10g, Radix Achyranthis Bidentatae 10g, Herba Cistanches 5g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 5g, Radix Et Caulis Acanthopanacis Senticosi 10g, Radix Tylophorae arenicolae 4g, Herba Crotalariae Ferrugineae 5g, Rhizoma Cimicifugae 5g, Semen Abutili 4g.
The pharmacologically active of each raw material of Chinese medicine of the present invention is as follows:
Rhizoma Polygonati Verticillati is the rhizome of liliaceous plant Gansu Rhizoma Polygonati or rose-red Rhizoma Polygonati, sweet, flat, nourishing the liver and kidney, YIN nourishing and the production of body fluid promoting.For neurasthenia, hypertension, headache, throat pain, quenches one's thirst, dry mouth and tougue.
Anoectochilus nefiliforme (Nakai) hara is the herb of orchid Anoectochilus Roxburghii and Anoectochilus nefiliforme (Nakai) hara, sweet, cool, returns lung, liver, kidney, urinary bladder channel, clearing away heat and cooling blood; Removing dampness and detoxicating.For hemoptysis of pulmonary tuberculosis, diabetes, nephritis, cystitis, myasthenia gravis, rheumatic and rheumatoid arthritis, venom.
Semen juglandis, is the kernel of juglandaceae plant Semen Juglandis, returns kidney, lung meridian, tonifying the kidney to consolidate the essence, warming the lung Dingchuan, intestine moistening, and controlling suffers from a deficiency of the kidney breathes heavily and cough, lumbago flaccidity of the lower limbs, sexual impotence, seminal emission, frequent micturition, stranguria caused by urinary stone, constipation due to dry stool." detailed outline ": benefiting qi and nourishing blood, moistening the lung and resolving the phlegm, the beneficial gate of vitality, profit three is burnt, warming the lung intestine moistening.Control deficiency and coldness to breathe heavily and cough, the heavy pain of waist foot, trusted subordinate's colic, dysentery hemorrhoidal hamorrhage, loose toxic swelling, sends out variola, and copper processed is malicious.
Radix Achyranthis Bidentatae is the root of amaranthaceous plant Radix Achyranthis Bidentatae, bitter, sour, flat, returns liver, kidney channel, invigorating the liver and kidney, bone and muscle strengthening, eliminating blood stasis and inducing menstruation, conducting blood to flow downwards.For soreness of waist and knee joint, muscles and bones is unable, amenorrhea lump in the abdomen, dizziness due to hyperactivity of liver-YANG." herbal classic ": " gonalgia can not be bent for main cold-damp flaccidity syndrome and arthralgia syndrome, spasm of the limbs, and by vim and vigour, fire of getting mildewed in warm conditions is rotten, induced abortion.″
Herba Cistanches, be the fleshy stem of orobanchaceae plant cistanche or Herba Cistanches, fan's Herba Cistanches etc., sweet, salty, temperature, returns kidney, large intestine channel, kidney-replenishing, benefiting essence-blood, loosening bowel to relieve constipation.For sexual impotence, infertile, soreness of the waist and knees, muscles and bones is unable, dryness of the intestine constipation.
Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. is the root of Passifloraceae plant Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep., and sweet, micro-hardship is cool, strengthening by means of tonics, wind-damp dispelling, the meridian dredging, tonifying and lifting QI.For strengthening the spleen and stomach, invigorating the liver and kidney.
Radix Et Caulis Acanthopanacis Senticosi, be the root of Araliaceae Radix Et Caulis Acanthopanacis Senticosi, rhizome or stem and leaf, pungent, micro-hardship, temperature, returns spleen, kidney, heart channel, replenishing QI to invigorate the spleen, tonifying the kidney for tranquilization.Replenishing kidney, strengthening waist; Benefiting vital QI for tranquillizing; Promoting blood circulation to remove obstruction in the collateral.Main kidney deficiency and bodily weakness; Soreness of the waist and knees; Children's's walking retardation in children; Insufficiency of the spleen weak; Deficiency of vital energy edema; Inappetence; Insomnia and dreamful sleep; Forgetful; Thoracic obstruction pain; Anemofrigid-damp arthralgia; Treating swelling and pain by traumatic injury.
Radix Tylophorae arenicolae, be the root and rhizome of peento in asclepiadaceae plant snow, bitter in the mouth, micro-pungent, property is put down, and returns lung meridian, clearing away heat and cooling blood, the kidney invigorating, spleen invigorating.Main fever due to yin deficiency; Asthenia chronic cough; Spitting of blood; Distending pain over the hypochondrium; Vomiting and nausea; Dysentery; Puerperal fidgets due to deficiency; Scrofula; Innominate toxic swelling; Serpentis worm; Mad dog is bitten." Shaanxi Chinese herbal medicine ": enriching yin and nourishing kidney, invigorating the spleen and benefiting QI, regulating menstruation and activating blood.Control menoxenia, deficiency of YIN leucorrhea.
Herba Crotalariae Ferrugineae, bitter micro-acid, flat cold, return lung meridian, nourishing the kidney and liver, relieving cough and asthma, eliminating damp, detoxifying.Main tinnitus, deaf, the vertigo, seminal emission, menorrhagia, leucorrhea, chronic cough expectorant blood, asthma, nephritis, dysuria, tonsillitis, parotitis, furuncle swelling toxin." vegetation is side just ": invigorating the spleen and replenishing QI, treat tinnitus, the head is giddy, collapses pouring.Pathogenic fire purging heat clearing away again, suppressing liver-wind, detumescence pain.
Rhizoma Cimicifugae is the root stock of ranunculaceae plant Rhizoma Cimicifugae, Cimicifuga Dahurica and C.heracleifolia, pungent, micro-sweet, is slightly cold, returns lung, spleen, stomach, large intestine channel, deliver rash, heat-clearing and toxic substances removing, elevate a turnable ladder yang-energy.For headache due to pathogenic wind-heat, toothache, aphtha, laryngopharynx swelling and pain, measles without adequate eruption, YANG toxin syndrome sends out speckle; Proctoptosis, uterine prolapse.
Semen Abutili, for Malvaceae plant Semen Abutili is used as medicine with root, stem, leaf and son, sweet, temperature, invigorating the spleen and replenishing QI; Weak for the deficiency of vital energy, soreness of the waist and knees, the empty spontaneous perspiration of body, proctoptosis, uterine prolapse, chronic nephritis, diabetes.
The present invention has following beneficial effect: Rhizoma Polygonati Verticillati, semen juglandis, Radix Achyranthis Bidentatae, Herba Cistanches, Herba Crotalariae Ferrugineae nourishing the liver and kidney, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep., Radix Et Caulis Acanthopanacis Senticosi, Radix Tylophorae arenicolae replenishing QI to invigorate the spleen, warp supported by Rhizoma Cimicifugae, Semen Abutili invigorating middle warmer, Anoectochilus nefiliforme (Nakai) hara clearing away heat-damp and promoting diuresis, all medicine compatibilities, play synergism, to myasthenia gravis determined curative effect, significantly, effective percentage is high, and has no side effect.
Detailed description of the invention
Be below specific embodiments of the invention, technical scheme of the present invention is described further, but protection scope of the present invention is not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
Embodiment 1
The Chinese medicine composition for the treatment of myasthenia gravis, is made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 10g, Anoectochilus nefiliforme (Nakai) hara 18g, semen juglandis 20g, Radix Achyranthis Bidentatae 15g, Herba Cistanches 10g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 3g, Radix Et Caulis Acanthopanacis Senticosi 8g, Radix Tylophorae arenicolae 5g, Herba Crotalariae Ferrugineae 6g, Rhizoma Cimicifugae 7g, Semen Abutili 3g.
Embodiment 2
The Chinese medicine composition for the treatment of myasthenia gravis, is made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 20g, Anoectochilus nefiliforme (Nakai) hara 20g, semen juglandis 15g, Radix Achyranthis Bidentatae 5g, Herba Cistanches 7g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 9g, Radix Et Caulis Acanthopanacis Senticosi 5g, Radix Tylophorae arenicolae 3g, Herba Crotalariae Ferrugineae 4g, Rhizoma Cimicifugae 10g, Semen Abutili 6g.
Embodiment 3
The Chinese medicine composition for the treatment of myasthenia gravis, is made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 15g, Anoectochilus nefiliforme (Nakai) hara 15g, semen juglandis 10g, Radix Achyranthis Bidentatae 10g, Herba Cistanches 5g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 5g, Radix Et Caulis Acanthopanacis Senticosi 10g, Radix Tylophorae arenicolae 4g, Herba Crotalariae Ferrugineae 5g, Rhizoma Cimicifugae 5g, Semen Abutili 4g.
Embodiment 4
The Chinese medicine composition for the treatment of myasthenia gravis, is made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 25g, Anoectochilus nefiliforme (Nakai) hara 10g, semen juglandis 5g, Radix Achyranthis Bidentatae 10g, Herba Cistanches 8g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 6g, Radix Et Caulis Acanthopanacis Senticosi 7g, Radix Tylophorae arenicolae 6g, Herba Crotalariae Ferrugineae 3g, Rhizoma Cimicifugae 9g, Semen Abutili 5g.
Clinical data
Physical data: accept for medical treatment altogether Patients With Myasthenia Gravis 74 example, wherein male 41 example, women 33 example, age 12-65 year.
Therapeutic Method: Chinese medicine composition of the present invention is decocted in water for oral dose, every day potion, one day twice, sooner or later sub-service 20 days was a course for the treatment of.
Curative effect judging standard:
Recovery from illness: clinical symptoms and sign disappear, can orthobiosis, study and work, more than 1 year without recurrence;
Effective: clinical symptoms and sign take an evident turn for the better, and self care ability is improved;
Invalid: clinical symptoms and sign, without improvement, even have deterioration.
Therapeutic outcome: in 74 routine patients, recovery from illness 51 example, effective 21 examples, invalid 2 examples, cure rate 68.9%, total effective rate 97.3%, determined curative effect, and in therapeutic process, patient does not occur that other are uncomfortable, has no side effect.
Model case
Liu, man, 21 years old, main cause Dual-eyelid was sagging, diplopia 6 months, increased the weight of companion's myasthenia of limbs and was admitted to hospital for 2 weeks.Bilateral blepharoptosis, diplopia, light dusk in morning is heavy, and alleviate after rest, tired postemphasis, is diagnosed as myasthenia gravis on inspection.Fully recover with after 1 course for the treatment of of traditional Chinese medicine composition for treating of the present invention, follow up a case by regular visits to and do not recur for 1 year.
Claims (2)
1. treat a Chinese medicine composition for myasthenia gravis, it is characterized in that, be made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 10-25g, Anoectochilus nefiliforme (Nakai) hara 10-20g, semen juglandis 5-20g, Radix Achyranthis Bidentatae 5-15g, Herba Cistanches 5-10g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 3-9g, Radix Et Caulis Acanthopanacis Senticosi 5-10g, Radix Tylophorae arenicolae 3-6g, Herba Crotalariae Ferrugineae 3-6g, Rhizoma Cimicifugae 5-10g, Semen Abutili 3-6g.
2. the Chinese medicine composition for the treatment of myasthenia gravis as claimed in claim 1, is characterized in that, be made up of the raw material of Chinese medicine of following weight proportioning: Rhizoma Polygonati Verticillati 15g, Anoectochilus nefiliforme (Nakai) hara 15g, semen juglandis 10g, Radix Achyranthis Bidentatae 10g, Herba Cistanches 5g, Adenia heterophylla (Bl.) Koord.[A.che-ualieri Gagnep. 5g, Radix Et Caulis Acanthopanacis Senticosi 10g, Radix Tylophorae arenicolae 4g, Herba Crotalariae Ferrugineae 5g, Rhizoma Cimicifugae 5g, Semen Abutili 4g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410583935.7A CN104274704A (en) | 2014-10-28 | 2014-10-28 | Traditional Chinese medicine composition for treating myasthenia gravis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410583935.7A CN104274704A (en) | 2014-10-28 | 2014-10-28 | Traditional Chinese medicine composition for treating myasthenia gravis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104274704A true CN104274704A (en) | 2015-01-14 |
Family
ID=52250365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410583935.7A Pending CN104274704A (en) | 2014-10-28 | 2014-10-28 | Traditional Chinese medicine composition for treating myasthenia gravis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104274704A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106472A (en) * | 2015-09-17 | 2015-12-02 | 吴开慧 | Traditional Chinese medicine composition for treating myasthenia gravis |
| CN105343634A (en) * | 2015-12-11 | 2016-02-24 | 冯复利 | Nursing traditional Chinese medicine for treating myasthenia gravis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1183980A (en) * | 1997-08-02 | 1998-06-10 | 迟经惠 | Decoction for serious amyasthenia |
| KR20140003727A (en) * | 2012-06-26 | 2014-01-10 | 성균관대학교산학협력단 | Composition containing dipterocarpus tuberculatus extract for treating or preventing inflammatory diseases or autoimmune diseases |
-
2014
- 2014-10-28 CN CN201410583935.7A patent/CN104274704A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1183980A (en) * | 1997-08-02 | 1998-06-10 | 迟经惠 | Decoction for serious amyasthenia |
| KR20140003727A (en) * | 2012-06-26 | 2014-01-10 | 성균관대학교산학협력단 | Composition containing dipterocarpus tuberculatus extract for treating or preventing inflammatory diseases or autoimmune diseases |
Non-Patent Citations (2)
| Title |
|---|
| 方思远: "方振千老中医验案3则", 《新中医》 * |
| 钟灼等: "《家庭医疗保健丛书（第一辑）·风湿病》", 31 May 2003, 广州出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105106472A (en) * | 2015-09-17 | 2015-12-02 | 吴开慧 | Traditional Chinese medicine composition for treating myasthenia gravis |
| CN105343634A (en) * | 2015-12-11 | 2016-02-24 | 冯复利 | Nursing traditional Chinese medicine for treating myasthenia gravis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106177860A (en) | A kind of medicated wine treating hyperosteogeny and preparation method thereof | |
| CN105362711A (en) | Plaster for treating pain of bone injury and preparation method thereof | |
| CN104042685A (en) | Externally-applied powder drug for treating scabies and preparing method thereof | |
| CN104274704A (en) | Traditional Chinese medicine composition for treating myasthenia gravis | |
| CN105012521A (en) | Traditional Chinese medicine composition treating prostate diseases | |
| CN105012430A (en) | Sciatica treating medicine and preparation method thereof | |
| CN103656510B (en) | One treats periostitic Chinese medicine decoction | |
| CN106110237A (en) | A kind of decoction medicine treating angina pectoris and preparation method thereof | |
| CN105343604A (en) | Traditional Chinese medicine pills for kidney yang deficiency type chronic pyelonephritis and preparation method thereof | |
| CN101647988A (en) | Medicine for treating pulmonary disease | |
| CN104740304A (en) | Traditional Chinese medicine pills for treating scapulohumeral periarthritis and preparation method thereof | |
| CN104189661A (en) | Traditional Chinese medicine for treating fibromyalgia syndrome | |
| CN103705676B (en) | A kind of Chinese medicine preparation preventing and treating thromboangiitis obliterans | |
| CN103751642B (en) | A kind of Chinese medicine composition for the treatment of gout | |
| CN107468893A (en) | A kind of pill medicine for treating habitual constipation and preparation method thereof | |
| CN107137689A (en) | A kind of Chinese medicine composition for treating menopausal syndrome | |
| CN105343634A (en) | Nursing traditional Chinese medicine for treating myasthenia gravis | |
| CN106266566A (en) | A kind of pill medicine treating cervical spondylosis and preparation method thereof | |
| CN106266833A (en) | A kind of Chinese medicine composition treating beriberoid pyretic arthralgia and preparation method | |
| CN105853931A (en) | Traditional Chinese medicine composition for nursing chilblain | |
| CN105125786A (en) | Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method thereof | |
| CN104587130A (en) | Traditional Chinese medicine composition for treating acute glomerulonephritis | |
| CN104474372A (en) | Pill for fracture postoperative rehabilitation therapy and preparation method | |
| CN104189815A (en) | Traditional Chinese medicine preparation for treating children bronchial asthma | |
| CN104013932B (en) | Traditional Chinese medicine pill for treating endogenous cough |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150114 |
|
| RJ01 | Rejection of invention patent application after publication |